SBI Live Webinar: Breast Cryoablation 

Presented by: Robert C. Ward, MD

This live webinar will be a comprehensive review of breast cryoablation. The talk will review the existing literature; examine the mechanism of action for treating breast cancer; there will be a thorough discussion about how to implement this service line in practice; practical tips and tricks for performing the procedure will be demonstrated; post ablation imaging findings will be illustrated; and there will be discussion of potential future applications, including the combination of cryoablation with immunotherapy. Come with your questions for the live Q&A! 

CME Information

Earn up to 1 AMA PRA Category 1 Credit^TM

Physicians Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits^TM for physicians. Physiciansshould claim only the credit commensurate with the extent of their participation in the activity.

Learner Notice

Acknowledgement of Financial Commercial Support- No financial commercial support was received for this educational activity.

Acknowledgement of In-Kind Commercial Support No in-kind commercial support was received for this educational activity.

Satisfactory Completion

Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. You must attend the entire webinar as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Breast Imaging . Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians- Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits^TM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflict of Interest

The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5)

All individuals in a position to control the content of CE are listed below.

SBI Live Webinar: MOD

Presented by: Manisha Bahl, MD, FSBI and Eun Langman, MD

CME Information

Coming soon!

SBI Live Webinar: Missed Breast Cancers at Mammography, CEM & Beyond

Presented by: Gul Icten, MD and Danielle Summers, MD

CME Information

Coming soon!

SBI Live Webinar: Common and Uncommon Inflammatory Breast Diseases

Presented by: Afsaneh Alikhassi, MD, Katharine Lampen-Sachar, MD, and Cedric Pluguez-Turull, MD

CME Information

Coming soon!

Descripción de la Presentación: Tamizaje Suplementario Para la Detección de Cáncer de Seno

Aproximadamente el 40% de las mujeres mayores de 40 años de edad tienen senos densos (1). El tejido denso reduce la efectividad de la mamografía y aumenta el riesgo de desarrollar cáncer de seno. Las mujeres con senos densos están a un mayor riesgo de padecer de cánceres de intervalo con un mayor estadío (2). Al añadir el tamizaje suplementario a la mamografía debemos detectar el cáncer de seno más temprano que de otra manera sería detectado clínicamente como una masa palpable. En esta presentación discutiremos tamizaje suplementario para la detección de cáncer de seno incluyendo: tomosíntesis, ecografía, resonancia magnética, imágenes moleculares de seno y mamografía de contraste. Referencias: 1. Sprague BL, Gangnon RE, Burt V, et al. Prevalence of mammographically dense breasts in the United States. J Natl Cancer Inst 2014;106(10):10.1093/jnci/dju255. Print 2014 Oct. 2. Arora N, King TA, Jacks LM, et al. Impact of breast density on the presenting features of malignancy. Ann Surg Oncol 2010;17 Suppl 3:211-218.

Approximately 40% of women over 40 years of age have dense breasts (1). Dense tissue reduces the effectiveness of mammography and increases the risk of developing breast cancer. Women with dense breasts are at increased risk for higher stage interval cancers (2). By adding supplemental screening to mammography, we should detect breast cancer earlier than would otherwise be detected clinically as a palpable mass. In this presentation, we will discuss supplemental screening for breast cancer detection, including tomosynthesis, ultrasound, magnetic resonance imaging, molecular breast imaging, and contrast mammography. References: 1. Sprague BL, Gangnon RE, Burt V, et al. Prevalence of mammographically dense breasts in the United States. J Natl Cancer Inst 2014;106(10):10.1093/jnci/dju255. Print 2014 Oct. 2. Arora N, King TA, Jacks LM, et al. Impact of breast density on the presenting features of malignancy. Ann Surg Oncol 2010;17 Suppl 3:211-218.

Registration Coming Soon! 

SBI Live Webinar: A Successful Dense Breast Screening Program

This session explores the critical role of ABUS and AI in enhancing early cancer detection among women with dense breast tissue. Highlighting the limitations of mammography in this population, the lecture emphasizes the importance of complementary modalities to improve diagnostic accuracy and patient outcomes. Discover how advanced technologies are reshaping breast cancer screening, ensuring comprehensive care tailored to individual patient needs. 

CME & Registration Details Coming Soon!